News|Articles|August 25, 2023

Promoting Hepatitis B Vaccination

With low vaccine utilization rates, finding educational resources to inform the public and increase attention to this preventative measure is needed to increase vaccinations.

Health officials have called attention to the discouraging reports that hepatitis B (HBV) vaccination coverage continues to fall short of goals since the vaccine was developed over three decades ago in 1986.

In addition to controlling the spread of the HBV, the vaccine was the first to prevent one type of cancer giving hope that others can be developed to address other diseases.

Over the years, major media campaigns have encouraged everyone to be HBV vaccinated against a virus that attacks the body's internal life creating and support system, the liver and hundreds of its cells. Unfortunately, the liver is its own worst enemy. Hidden under the ribs, it is incapable of eliciting pain or other warning signs to alert its owner.

However, most people are totally unaware of their liver or how it performs. This information is essential to empowering and motivating people to get vaccinated.

Educating the masses with pertinent information is essential in motivating individuals to comply with recommendations. Without the protection of the HBV vaccine and lacking liver information, they may unknowingly continue to participate in liver damaging activities that expose them to hepatitis, cirrhosis, cancer and the development of numerous other liver related diseases that can lead to other potentially preventable diseases.

For example, this podcast hosts an interview with Joshua Sharfstein MD, vice dean, Johns Hopkins Bloomberg School of Public Health. Sharfstein explains complex liver functions in a personalized, relatable, and understandable manner that provides individuals with important information. In addition, there are educational resources for various ages on our website. Children can learn about their liver from a happy little liver character that teaches them about it in a coloring book, Liv and Lucky in Liverland.

The Liver Health Initiative can help in providing education and information. Interested parties can also call 301-625-9076 to schedule a meeting.


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
FAQ: Shamonda Virus
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.